Payment overview · 2025
General Payments
$102.16
2 reported records · 1 companies
Healthcare provider profile · identity verified
Daniel Joseph Hurley, M.D.
Allopathic & Osteopathic Physicians|Internal Medicine|Geriatric Medicine · INDIANAPOLIS, IN · NPI 1750432969
Verified facts
What the public records show
CMS Open Payments records show Daniel Joseph Hurley, M.D. received $102.16 in general payments during 2025 across 2 reported records.
SUN PHARMACEUTICAL INDUSTRIES INC. accounted for 100.0% of that reported general-payment amount.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| SUN PHARMACEUTICAL INDUSTRIES INC. | Unresolved — no canonical attribution shown | $102.16 | 100.0% | 2 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $102.16 | 2 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
Payment records were found, but the reported records did not identify a specific associated product for this analysis.
Public prescribing for products named in payments
There is no explicit payment-product set available for a Part D comparison.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
No publishable same-company prescribing overlap was found in the loaded Part D year. This does not mean the doctor never prescribed a drug reported elsewhere by a paying company.
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Atorvastatin Calcium | Atorvastatin Calcium | 560 | 84 |
| Levothyroxine Sodium | Levothyroxine Sodium | 382 | 53 |
| Omeprazole | Omeprazole | 331 | 51 |
| Eliquis | Apixaban | 311 | 34 |
| Lisinopril | Lisinopril | 262 | 38 |
| Amlodipine Besylate | Amlodipine Besylate | 255 | 47 |
| Metoprolol Succinate | Metoprolol Succinate | 233 | 33 |
| Sertraline Hcl | Sertraline Hcl | 229 | 30 |
| Furosemide | Furosemide | 223 | 37 |
| Donepezil Hcl | Donepezil Hcl | 206 | 30 |
| Potassium Chloride | Potassium Chloride | 206 | 38 |
| Gabapentin | Gabapentin | 201 | 35 |
| Trazodone Hcl | Trazodone Hcl | 183 | 31 |
| Tamsulosin Hcl | Tamsulosin Hcl | 164 | 24 |
| Metformin Hcl | Metformin Hcl | 151 | 26 |
| Losartan Potassium | Losartan Potassium | 143 | 26 |
| Duloxetine Hcl | Duloxetine Hcl | 137 | 24 |
| Memantine Hcl | Memantine Hcl | 133 | 16 |
| Pantoprazole Sodium | Pantoprazole Sodium | 128 | 22 |
| Mirtazapine | Mirtazapine | 127 | 24 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 126 | 26 |
| Allopurinol | Allopurinol | 123 | 15 |
| Torsemide | Torsemide | 111 | 19 |
| Famotidine | Famotidine | 108 | 16 |
| Januvia | Sitagliptin Phosphate | 98 | suppressed |
| Carvedilol | Carvedilol | 97 | 15 |
| Metoprolol Tartrate | Metoprolol Tartrate | 96 | 20 |
| Escitalopram Oxalate | Escitalopram Oxalate | 90 | 13 |
| Tramadol Hcl | Tramadol Hcl | 89 | 21 |
| Myrbetriq | Mirabegron | 88 | 12 |
| Levetiracetam | Levetiracetam | 87 | 14 |
| Clopidogrel | Clopidogrel Bisulfate | 85 | 14 |
| Buspirone Hcl | Buspirone Hcl | 81 | 13 |
| Lamotrigine | Lamotrigine | 78 | suppressed |
| Quetiapine Fumarate | Quetiapine Fumarate | 73 | 11 |
| Montelukast Sodium | Montelukast Sodium | 68 | suppressed |
| Hydrochlorothiazide | Hydrochlorothiazide | 66 | 14 |
| Prednisone | Prednisone | 66 | 17 |
| Bupropion Xl | Bupropion Hcl | 64 | suppressed |
| Citalopram Hbr | Citalopram Hydrobromide | 64 | suppressed |
| Xarelto | Rivaroxaban | 62 | suppressed |
| Finasteride | Finasteride | 59 | suppressed |
| Olanzapine | Olanzapine | 56 | suppressed |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 51 | suppressed |
| Jardiance | Empagliflozin | 51 | suppressed |
| Loperamide | Loperamide Hcl | 50 | 17 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 49 | 22 |
| Glipizide | Glipizide | 49 | suppressed |
| Galantamine Hbr | Galantamine Hbr | 48 | suppressed |
| Divalproex Sodium | Divalproex Sodium | 47 | 11 |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 47 | suppressed |
| Risperidone | Risperidone | 46 | 11 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 45 | suppressed |
| Hydralazine Hcl | Hydralazine Hcl | 44 | 12 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 42 | suppressed |
| Autoshield Duo Pen Needle | Pen Needle,dual Safety,diabetc | 40 | 11 |
| Ropinirole Hcl | Ropinirole Hcl | 40 | suppressed |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 39 | suppressed |
| Lactulose | Lactulose | 39 | suppressed |
| Vascepa | Icosapent Ethyl | 38 | suppressed |
| Aripiprazole | Aripiprazole | 37 | suppressed |
| Simvastatin | Simvastatin | 37 | suppressed |
| Pramipexole Dihydrochloride | Pramipexole Di-Hcl | 35 | suppressed |
| Arexvy | Rsvpref3 Antigen/As01e/Pf | 34 | 30 |
| Clozapine | Clozapine | 34 | suppressed |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 33 | 20 |
| Spironolactone | Spironolactone | 33 | suppressed |
| Metformin Hcl Er | Metformin Hcl | 31 | suppressed |
| Pregabalin | Pregabalin | 30 | suppressed |
| Bupropion Hcl | Bupropion Hcl | 29 | suppressed |
| Atenolol | Atenolol | 28 | suppressed |
| Fluoxetine Hcl | Fluoxetine Hcl | 28 | suppressed |
| Incruse Ellipta | Umeclidinium Bromide | 28 | suppressed |
| Trimethoprim | Trimethoprim | 27 | suppressed |
| Dicyclomine Hcl | Dicyclomine Hcl | 26 | suppressed |
| Ezetimibe | Ezetimibe | 26 | suppressed |
| Ondansetron Odt | Ondansetron | 26 | 15 |
| Tradjenta | Linagliptin | 26 | suppressed |
| Alendronate Sodium | Alendronate Sodium | 25 | suppressed |
| Breo Ellipta | Fluticasone/Vilanterol | 25 | suppressed |
| Bupropion Hcl Sr | Bupropion Hcl | 25 | suppressed |
| Latanoprost | Latanoprost | 25 | suppressed |
| Farxiga | Dapagliflozin Propanediol | 24 | suppressed |
| Memantine Hcl Er | Memantine Hcl | 24 | suppressed |
| Midodrine Hcl | Midodrine Hcl | 24 | suppressed |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 23 | suppressed |
| Doxycycline Hyclate | Doxycycline Hyclate | 23 | 17 |
| Glipizide Er | Glipizide | 23 | suppressed |
| Insulin Glargine-Yfgn | Insulin Glargine-Yfgn | 23 | 12 |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 21 | 14 |
| Diclofenac Sodium | Diclofenac Sodium | 21 | suppressed |
| Paxlovid (Eua) | Nirmatrelvir/Ritonavir | 21 | 21 |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 20 | suppressed |
| Lorazepam | Lorazepam | 20 | suppressed |
| Namzaric | Memantine Hcl/Donepezil Hcl | 20 | suppressed |
| Sucralfate | Sucralfate | 20 | suppressed |
| Baclofen | Baclofen | 19 | suppressed |
| Lacosamide | Lacosamide | 19 | suppressed |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 18 | suppressed |
| Paroxetine Hcl | Paroxetine Hcl | 18 | suppressed |
| Telmisartan | Telmisartan | 18 | suppressed |
| Alprazolam | Alprazolam | 17 | suppressed |
| Ibuprofen | Ibuprofen | 17 | suppressed |
| Pravastatin Sodium | Pravastatin Sodium | 17 | suppressed |
| Carbamazepine Er | Carbamazepine | 16 | suppressed |
| Celecoxib | Celecoxib | 16 | suppressed |
| Cephalexin | Cephalexin | 16 | suppressed |
| Creon | Lipase/Protease/Amylase | 16 | suppressed |
| Gemfibrozil | Gemfibrozil | 16 | suppressed |
| Benztropine Mesylate | Benztropine Mesylate | 15 | suppressed |
| Cefuroxime | Cefuroxime Axetil | 15 | 13 |
| Clonazepam | Clonazepam | 15 | suppressed |
| Colestipol Hcl | Colestipol Hcl | 15 | suppressed |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 15 | suppressed |
| Meclizine Hcl | Meclizine Hcl | 15 | suppressed |
| Primidone | Primidone | 15 | suppressed |
| Cyclosporine | Cyclosporine | 14 | suppressed |
| Estradiol | Estradiol | 14 | suppressed |
| Fluconazole | Fluconazole | 14 | suppressed |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 14 | suppressed |
| Amitriptyline Hcl | Amitriptyline Hcl | 13 | suppressed |
| Anastrozole | Anastrozole | 13 | suppressed |
| Aptiom | Eslicarbazepine Acetate | 13 | suppressed |
| Basaglar Kwikpen U-100 | Insulin Glargine,hum.Rec.Anlog | 13 | suppressed |
| Brimonidine Tartrate | Brimonidine Tartrate | 13 | suppressed |
| Chlorthalidone | Chlorthalidone | 13 | suppressed |
| Dextrose 5%-0.45% Nacl | Dextrose 5 %-0.45 % Sod Chlord | 13 | suppressed |
| Prazosin Hcl | Prazosin Hcl | 13 | suppressed |
| Promethazine Hcl | Promethazine Hcl | 13 | suppressed |
| Amantadine | Amantadine Hcl | 12 | suppressed |
| Divalproex Sodium Er | Divalproex Sodium | 12 | suppressed |
| Doxepin Hcl | Doxepin Hcl | 12 | suppressed |
| Fenofibrate | Fenofibrate | 12 | suppressed |
| Fluocinonide | Fluocinonide | 12 | suppressed |
| Fluphenazine Hcl | Fluphenazine Hcl | 12 | suppressed |
| Haloperidol | Haloperidol | 12 | suppressed |
| M-Natal Plus | Pnv,calcium 72/Iron/Folic Acid | 12 | suppressed |
| Nystatin | Nystatin | 12 | suppressed |
| Olmesartan Medoxomil | Olmesartan Medoxomil | 12 | suppressed |
| Phenobarbital | Phenobarbital | 12 | suppressed |
| Pioglitazone Hcl | Pioglitazone Hcl | 12 | suppressed |
| Terazosin Hcl | Terazosin Hcl | 12 | suppressed |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 12 | suppressed |
| Ventolin Hfa | Albuterol Sulfate | 12 | suppressed |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 11 | suppressed |
| Desmopressin Acetate | Desmopressin Acetate | 11 | suppressed |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 11 | suppressed |
| Fluticasone Propionate | Fluticasone Propionate | 11 | suppressed |
| Insulin Lispro | Insulin Lispro | 11 | suppressed |
| Insulin Lispro Kwikpen U-100 | Insulin Lispro | 11 | suppressed |
| Labetalol Hcl | Labetalol Hcl | 11 | suppressed |
| Medroxyprogesterone Acetate | Medroxyprogesterone Acetate | 11 | suppressed |
| Methocarbamol | Methocarbamol | 11 | suppressed |
| Modafinil | Modafinil | 11 | suppressed |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $102.16 · 2 records | SUN PHARMACEUTICAL INDUSTRIES INC. | — | — | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error